×
Serum Lipoproteins Improve After Successful Pharmacologic Antidepressant Treatment: A Randomized Open-Label Prospective Trial PDF
$ 40.00
Serum Lipoproteins Improve After Successful Pharmacologic Antidepressant Treatment: A Randomized Open-Label Prospective Trial PDF quantity
$ 40.00
×
Citalopram Treatment of Fluoxetine Nonresponders PDF
$ 40.00
Citalopram Treatment of Fluoxetine Nonresponders PDF quantity
$ 40.00
×
Suicide in Schizophrenia: An Observational Study of Coroner Records in Toronto PDF
$ 40.00
Suicide in Schizophrenia: An Observational Study of Coroner Records in Toronto PDF quantity
$ 40.00
×
Cognitive Change in the Year After a First Manic Episode: Association Between Clinical Outcome and Cognitive Performance Early in the Course of Bipolar I Disorder PDF
$ 40.00
Cognitive Change in the Year After a First Manic Episode: Association Between Clinical Outcome and Cognitive Performance Early in the Course of Bipolar I Disorder PDF quantity
$ 40.00
×
The Development of Study Exit Criteria for Evaluating Antimanic Compounds PDF
$ 40.00
The Development of Study Exit Criteria for Evaluating Antimanic Compounds PDF quantity
$ 40.00
×
Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis PDF
$ 40.00
Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis PDF quantity
$ 40.00
×
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression PDF
$ 40.00
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression PDF quantity
$ 40.00
×
Demographics, Clinical Characteristics, and Treatment of Aggressive Patients Admitted to the Acute Behavioral Unit of a Community General Hospital: A Prospective Observational Study PDF
$ 40.00
Demographics, Clinical Characteristics, and Treatment of Aggressive Patients Admitted to the Acute Behavioral Unit of a Community General Hospital: A Prospective Observational Study PDF quantity
$ 40.00
×
Monthly Administration of Long-Acting Injectable Risperidone and Striatal Dopamine D2 Receptor Occupancy for the Management of Schizophrenia PDF
$ 40.00
Monthly Administration of Long-Acting Injectable Risperidone and Striatal Dopamine D2 Receptor Occupancy for the Management of Schizophrenia PDF quantity
$ 40.00
×
A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment PDF
$ 40.00
A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart